FI852807L - Nya foereningar. - Google Patents

Nya foereningar.

Info

Publication number
FI852807L
FI852807L FI852807A FI852807A FI852807L FI 852807 L FI852807 L FI 852807L FI 852807 A FI852807 A FI 852807A FI 852807 A FI852807 A FI 852807A FI 852807 L FI852807 L FI 852807L
Authority
FI
Finland
Prior art keywords
image
foereningar
nya
nya foereningar
anion
Prior art date
Application number
FI852807A
Other languages
English (en)
Other versions
FI85019B (fi
FI85019C (fi
FI852807A0 (fi
Inventor
Roy Archibald Swaringen Jr
Hassan Ali El-Sayad
David Arthur Yeowell
John Joseph Savarese
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of FI852807A0 publication Critical patent/FI852807A0/fi
Publication of FI852807L publication Critical patent/FI852807L/fi
Publication of FI85019B publication Critical patent/FI85019B/fi
Application granted granted Critical
Publication of FI85019C publication Critical patent/FI85019C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Jib Cranes (AREA)
  • Fats And Perfumes (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
FI852807A 1984-07-18 1985-07-17 Foerfarande foer framstaellning av terapeutiskt anvaendbara (e)-4-oktendioylbis (oxitrimetylen) bis (1,2,3,4-tetrahydro-6,7-dimetoxi-2-metyl-1-(3,4,5-trimetoxibensyl) isokinolinium) foereningar. FI85019C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8418303 1984-07-18
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (4)

Publication Number Publication Date
FI852807A0 FI852807A0 (fi) 1985-07-17
FI852807L true FI852807L (fi) 1986-01-19
FI85019B FI85019B (fi) 1991-11-15
FI85019C FI85019C (fi) 1992-02-25

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852807A FI85019C (fi) 1984-07-18 1985-07-17 Foerfarande foer framstaellning av terapeutiskt anvaendbara (e)-4-oktendioylbis (oxitrimetylen) bis (1,2,3,4-tetrahydro-6,7-dimetoxi-2-metyl-1-(3,4,5-trimetoxibensyl) isokinolinium) foereningar.

Country Status (30)

Country Link
US (1) US4761418A (fi)
EP (1) EP0181055B1 (fi)
JP (1) JPH0662568B2 (fi)
AT (1) ATE60759T1 (fi)
AU (1) AU574481B2 (fi)
BG (1) BG60411B2 (fi)
CA (1) CA1273341A (fi)
CY (1) CY1687A (fi)
DD (1) DD235638A5 (fi)
DE (2) DE3581699D1 (fi)
DK (1) DK168093B1 (fi)
ES (1) ES8609260A1 (fi)
FI (1) FI85019C (fi)
GB (1) GB8418303D0 (fi)
GE (1) GEP19960468B (fi)
HK (1) HK47593A (fi)
HU (1) HU193996B (fi)
IE (1) IE58138B1 (fi)
IL (1) IL75833A (fi)
LT (1) LT2078B (fi)
LU (1) LU88801I2 (fi)
LV (1) LV5483A3 (fi)
MC (1) MC1690A1 (fi)
MX (1) MX9203667A (fi)
NL (1) NL940023I2 (fi)
NZ (1) NZ212766A (fi)
PL (1) PL146066B1 (fi)
SG (1) SG3493G (fi)
SU (1) SU1468414A3 (fi)
ZA (1) ZA855407B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
WO1998042674A1 (en) * 1997-03-25 1998-10-01 Glaxo Group Limited Substituted isoquinolines as ultra short acting neuromuscular blockers
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
WO2005041960A2 (en) * 2003-10-28 2005-05-12 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
AU2007328210B2 (en) * 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
CA2680277A1 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
US20100087650A1 (en) * 2007-03-26 2010-04-08 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
CA2685488A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
BRPI0809893A2 (pt) * 2007-05-01 2014-09-30 Chemagis Ltd Processo para prepar um sal de (1r-cis) - [(3,4 - dimetoxifenil) metil] - 1, 2,3,4 - tetraidro - 6,7 - dimetoxi - 2 - metil - 2 - carboxietil - isoquinolínio"
CA2687157A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
BRPI0812625A2 (pt) * 2007-07-09 2019-02-19 Chemagis Ltd processo para preparar um sal de cis-atracúrio
WO2009057086A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel r,r'-atracurium salts
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
WO2009133556A2 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (zh) 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
EP2867219B1 (en) 2012-06-29 2017-02-15 Cornell University Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
ZA784331B (en) * 1977-08-01 1979-12-27 Massachusetts Gen Hospital Neuromuscular blocking agents
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
CA1153380A (en) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
DE3165714D1 (en) * 1980-12-17 1984-09-27 Wellcome Found Long duration neuromuscular blocking agents, pharmaceutical compositions containing them and processes for their preparation
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
LT2078B (lt) 1993-06-15
EP0181055B1 (en) 1991-02-06
AU4510885A (en) 1986-01-23
NZ212766A (en) 1988-03-30
DE19675039I2 (de) 2003-01-09
MC1690A1 (fr) 1986-07-18
JPH0662568B2 (ja) 1994-08-17
FI85019B (fi) 1991-11-15
IE851791L (en) 1986-01-18
IL75833A0 (en) 1985-11-29
DK168093B1 (da) 1994-02-07
DE3581699D1 (de) 1991-03-14
PL146066B1 (en) 1988-12-31
HK47593A (en) 1993-05-21
SU1468414A3 (ru) 1989-03-23
DK324985D0 (da) 1985-07-17
JPS6187666A (ja) 1986-05-06
HU193996B (en) 1987-12-28
HUT40626A (en) 1987-01-28
ZA855407B (en) 1986-04-30
SG3493G (en) 1993-03-12
LU88801I2 (fr) 1996-11-05
ES8609260A1 (es) 1986-09-01
AU574481B2 (en) 1988-07-07
EP0181055A1 (en) 1986-05-14
FI85019C (fi) 1992-02-25
NL940023I1 (nl) 1995-01-02
DD235638A5 (de) 1986-05-14
IE58138B1 (en) 1993-07-14
US4761418A (en) 1988-08-02
MX9203667A (es) 1992-07-31
LV5483A3 (lv) 1994-03-10
ATE60759T1 (de) 1991-02-15
CY1687A (en) 1993-10-10
PL254571A1 (en) 1986-07-15
BG60411B2 (bg) 1995-02-28
NL940023I2 (nl) 1998-06-02
GEP19960468B (en) 1996-08-29
IL75833A (en) 1988-11-30
CA1273341A (en) 1990-08-28
FI852807A0 (fi) 1985-07-17
GB8418303D0 (en) 1984-08-22
ES545319A0 (es) 1986-09-01
DK324985A (da) 1986-01-19

Similar Documents

Publication Publication Date Title
FI852807L (fi) Nya foereningar.
ES538757A0 (es) Procedimiento para la preparacion de 11b-aril-estradienos
ZA862289B (en) Application of azolylmethyloxiranes for the treatmazolylmethyloxiranes,their preparation and their uent of viral diseases se as crop protection agents
ZA857270B (en) Tetralin derivatives,their preparation and their use
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
IL72354A0 (en) Imidazolium salts,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
DE3785046A1 (fi)
NO161972C (no) Analogifremgamgsmaate ved fremstilling av terapeutisk aktive 1-substituerte tetralinderivater.
NZ217418A (en) Tricyclic heterocyclic compounds and pharmaceutical compositions
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
NO162557C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner.
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
ZA796789B (en) Novel 3,4-diaza-bicyclo (4.1.0) hept-2-en-5-ones, their preparation, and therapeutic agents containing these compounds
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
ES520206A0 (es) Procedimiento para la preparacion de 11 -cloro-15-esteroides.
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
DK159184A (da) Pterinforbindelser
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L39

Extension date: 20071208

FG Patent granted

Owner name: THE GENERAL HOSPITAL CORPORATION

Owner name: THE WELLCOME FOUNDATION LIMITED

MA Patent expired